Medication Assisted Treatment for Alcohol Use Disorder

In this presentation, Dr. Colleen Keough discusses pharmaceutical treatment options for patients with a substance abuse disorder, particularly alcohol and opioid use disorders. She focuses on practice recommendations for general internists, and includes resources for screening tools and overdose prevention.
This Section of General Internal Medicine Series session took place on Wednesday, April 12, 2023 at 12:15 p.m.

Activity Information

How to Claim Credit

You may claim credit after watching this activity.

You will be redirected to the BCM DCPD credit management site when claiming credit and may be asked to register or log in.

Needs Statement

General internal medicine faculty physicians and allied health practitioners in inpatient and outpatient settings need to receive regular updates on current evidence-based guidelines for general internal medicine practice, effective transitions of care, and other systems-based practices. The series aims to reach the wider audience of general internal medicine practitioners at Ben Taub Hospital, the Baylor Clinic, the Harris Health System, the Baylor St. Luke's Medical Center, and the Michael E. DeBakey VA Medical Center. The series also aims to address the challenges of developing and implementing quality improvement strategies and maintaining quality patient care as general internal medicine practices continue to evolve. Emphasis will be placed on the importance of professional development activities, such as teaching and scholarship, as a means to keep knowledge of evolving general internal medicine practices current.

Educational Objectives

At the conclusion of the session, the participants should be able to:

  • Evaluate patients with alcohol use disorder for medication assisted treatment.
  • List medication treatment options for patients with alcohol use disorder.
  • Utilize a patient-centered approach to discussing treatment options with patients.
  • Develop and apply strategies for medication assisted treatment for alcohol use disorder to patient care.

Target Audience

Professional Categories

  • Physicians
  • Medical Students
  • Fellows
  • Residents
  • Nurses
  • Other Health Professionals

Specialties

  • Internal Medicine

Interest Groups

  • Hospital Medicine
  • Pain Management

Activity Evaluation

Evaluation by questionnaire will address program content, presentation, and possible bias.

Educational Methods

  • Lectures

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been designated by Baylor College of Medicine for 1 credit of education in pain management and the prescription of opioids.

Activity Directors

  1. Joslyn W. Fisher, M.D., M.P.H.

    Joslyn W. Fisher, M.D., M.P.H.

    Associate Professor
    Baylor College of Medicine
  2. Cara A. Foldes, M.D., M.P.H.

    Cara A. Foldes, M.D., M.P.H.

    Assistant Professor
    Baylor College of Medicine

Term of Approval

April 1, 2023 through April 30, 2025. Original release date: April 1, 2023.

Disclosure Policy

Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.

In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.

In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.

BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.

All of the relevant financial relationships listed for these individuals have been mitigated.

Disclosures

The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:

Presenter

  1. Colleen Alyssa Keough, M.D., M.P.H.

    Colleen Alyssa Keough, M.D., M.P.H.

    Assistant Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

Activity Directors

  1. Joslyn W. Fisher, M.D., M.P.H.

    Joslyn W. Fisher, M.D., M.P.H.

    Associate Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  2. Cara A. Foldes, M.D., M.P.H.

    Cara A. Foldes, M.D., M.P.H.

    Assistant Professor
    Baylor College of Medicine

    Disclosure:
    • Ownership Interests (stock, stock options, excluding diversified mutual funds): IBM (stockholder)

Planning Committee Members

  1. Fabrizio Canepa Escaro, M.D. Placeholder Image

    Fabrizio Canepa Escaro, M.D.

    Assistant Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  2. Joslyn W. Fisher, M.D., M.P.H.

    Joslyn W. Fisher, M.D., M.P.H.

    Associate Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  3. Cara A. Foldes, M.D., M.P.H.

    Cara A. Foldes, M.D., M.P.H.

    Assistant Professor
    Baylor College of Medicine

    Disclosure:
    • Ownership Interests (stock, stock options, excluding diversified mutual funds): IBM (stockholder)
  4. Sonal Gadicherla, M.D.

    Sonal Gadicherla, M.D.

    Assistant Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  5. Kristen Lavere, M.D.

    Kristen Lavere, M.D.

    Internal Medicine Resident
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  6. Cody Moore, M.D. Placeholder Image

    Cody Moore, M.D.

    Assistant Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  7. Stephanie Sherman, M.D.

    Stephanie Sherman, M.D.

    Assistant Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  8. Isabel Valdez, PA-C, MPAS, CPAAPA

    Isabel Valdez, PA-C, MPAS, CPAAPA

    Instructor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

Presenter:

Colleen Alyssa Keough, M.D., M.P.H.

Colleen Alyssa Keough, M.D., M.P.H.

Assistant Professor Baylor College of Medicine

Health Topics

You May Also Be Interested In

On Demand
Opioid Use Disorder Conference 2024
Activity duration: 30 min
Activity Available On Demand
Credit 0.50 Continuing Medical Education Credits Available
On Demand
Opioid Use Disorder Conference 2024
Activity duration: 30 min
Activity Available On Demand
Credit 0.50 Continuing Medical Education Credits Available
Live
Annual Wellness Visit
Activity Date Range: 9/1/24 - 9/1/26
Credit 1.50 Continuing Medical Education Credits Available